Literature DB >> 25778098

Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.

T Lana1, P de Lorenzo2,3, S Bresolin1, I Bronzini1, M L den Boer4,5, H Cavé6, E Froňková7, M Stanulla8,9, M Zaliova7,8,9, C J Harrison10, H de Groot5, M G Valsecchi3, A Biondi2, G Basso1, G Cazzaniga2, G te Kronnie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25778098     DOI： 10.1038/leu.2015.78

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Predicting deleterious amino acid substitutions.

Authors:  P C Ng; S Henikoff
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding.

Authors:  B S Cobb; S Morales-Alcelay; G Kleiger; K E Brown; A G Fisher; S T Smale
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

3.  Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

Authors:  Maurizio Aricò; Martin Schrappe; Stephen P Hunger; William L Carroll; Valentino Conter; Stefania Galimberti; Atsushi Manabe; Vaskar Saha; André Baruchel; Kim Vettenranta; Keizo Horibe; Yves Benoit; Rob Pieters; Gabriele Escherich; Lewis B Silverman; Ching-Hon Pui; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2010-09-27       Impact factor: 44.544

4.  The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.

Authors:  A Kohlmann; H-U Klein; S Weissmann; S Bresolin; T Chaplin; H Cuppens; E Haschke-Becher; B Garicochea; V Grossmann; B Hanczaruk; K Hebestreit; C Gabriel; I Iacobucci; J H Jansen; G te Kronnie; L van de Locht; G Martinelli; K McGowan; M R Schweiger; B Timmermann; P Vandenberghe; B D Young; M Dugas; T Haferlach
Journal:  Leukemia       Date:  2011-06-17       Impact factor: 11.528

5.  Refining prognosis in BCR-ABL1-positive ALL.

Authors:  Elizabeth A Raetz; William L Carroll
Journal:  Blood       Date:  2014-03-13       Impact factor: 22.113

6.  What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?

Authors:  Chiara Palmi; Maria Grazia Valsecchi; Giulia Longinotti; Daniela Silvestri; Valentina Carrino; Valentino Conter; Giuseppe Basso; Andrea Biondi; Geertruy Te Kronnie; Giovanni Cazzaniga
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

8.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

9.  Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros.

Authors:  Hilde Schjerven; Jami McLaughlin; Teresita L Arenzana; Seth Frietze; Donghui Cheng; Sarah E Wadsworth; Gregory W Lawson; Steven J Bensinger; Peggy J Farnham; Owen N Witte; Stephen T Smale
Journal:  Nat Immunol       Date:  2013-09-08       Impact factor: 25.606

10.  IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.

Authors:  Arian van der Veer; Marketa Zaliova; Federica Mottadelli; Paola De Lorenzo; Gertruuy Te Kronnie; Christine J Harrison; Hélène Cavé; Jan Trka; Vaskar Saha; Martin Schrappe; Rob Pieters; Andrea Biondi; Maria Grazia Valsecchi; Martin Stanulla; Monique L den Boer; Giovanni Cazzaniga
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113
View more
  7 in total

1.  Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.

Authors:  David Boutboul; Hye Sun Kuehn; Zoé Van de Wyngaert; Julie E Niemela; Isabelle Callebaut; Jennifer Stoddard; Christelle Lenoir; Vincent Barlogis; Catherine Farnarier; Frédéric Vely; Nao Yoshida; Seiji Kojima; Hirokazu Kanegane; Akihiro Hoshino; Fabian Hauck; Ludovic Lhermitte; Vahid Asnafi; Philip Roehrs; Shaoying Chen; James W Verbsky; Katherine R Calvo; Ammar Husami; Kejian Zhang; Joseph Roberts; David Amrol; John Sleaseman; Amy P Hsu; Steven M Holland; Rebecca Marsh; Alain Fischer; Thomas A Fleisher; Capucine Picard; Sylvain Latour; Sergio D Rosenzweig
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

Review 2.  The role of zinc and its compounds in leukemia.

Authors:  Alexey P Orlov; Marina A Orlova; Tatiana P Trofimova; Stepan N Kalmykov; Dmitry A Kuznetsov
Journal:  J Biol Inorg Chem       Date:  2018-02-28       Impact factor: 3.358

3.  Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.

Authors:  Michelle L Churchman; Maoxiang Qian; Geertruy Te Kronnie; Ranran Zhang; Wenjian Yang; Hui Zhang; Tobia Lana; Paige Tedrick; Rebekah Baskin; Katherine Verbist; Jennifer L Peters; Meenakshi Devidas; Eric Larsen; Ian M Moore; Zhaohui Gu; Chunxu Qu; Hiroki Yoshihara; Shaina N Porter; Shondra M Pruett-Miller; Gang Wu; Elizabeth Raetz; Paul L Martin; W Paul Bowman; Naomi Winick; Elaine Mardis; Robert Fulton; Martin Stanulla; William E Evans; Mary V Relling; Ching-Hon Pui; Stephen P Hunger; Mignon L Loh; Rupert Handgretinger; Kim E Nichols; Jun J Yang; Charles G Mullighan
Journal:  Cancer Cell       Date:  2018-04-19       Impact factor: 31.743

Review 4.  IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?

Authors:  Martin Stanulla; Hélène Cavé; Anthony V Moorman
Journal:  Blood       Date:  2020-01-23       Impact factor: 22.113

5.  Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma.

Authors:  Chang-Lung Lee; David G Kirsch; Kennedy D Brock; Stephanie Hasapis; Dadong Zhang; Alexander B Sibley; Xiaodi Qin; Jeremy S Gresham; Isibel Caraballo; Lixia Luo; Andrea R Daniel; Matthew J Hilton; Kouros Owzar
Journal:  Cancer Res       Date:  2021-05-25       Impact factor: 12.701

Review 6.  AIOLOS Variants Causing Immunodeficiency in Human and Mice.

Authors:  Motoi Yamashita; Tomohiro Morio
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

Review 7.  Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy.

Authors:  Linda Rossini; Caterina Durante; Silvia Bresolin; Enrico Opocher; Antonio Marzollo; Alessandra Biffi
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.